Gene Therapy Cell Culture Media Market

Best Price Guarantee	Publisher	Published Date	SKU
from $3,475	Evolve Business Intelligence	April, 2025	EVBI19932123

Best Price Guarantee
Price	from $3,475
Publisher	Evolve Business Intelligence
Published Date	April, 2025
SKU	EVBI19932123

The Gene Therapy Cell Culture Media Market is projected to grow from USD 6.21 billion in 2023 to USD 54.41 billion by 2033, reflecting a compound annual growth rate (CAGR) of 12.30% over this period. This market encompasses the biotechnology and pharmaceutical sectors, focusing on the development, production, and commercialization of specialized culture media tailored for gene therapy applications. The growth of this market is driven by increasing investments in gene therapy research and development, advancements in biotechnology, and the rising demand for effective treatments for genetic disorders.

The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.

Segments covered

By Product Type (Media, Viral Vectors)
By Application (Biotechnology & Pharmaceutical Industry, Research Laboratory, Academic Institute, Others)

Key players

Fujifilm Holdings Corporation.
HiMedia Laboratories
Lonza Group Ltd.
Sartorius AG
Thermo Fisher Scientific Inc.
Merck KGaA
Danaher Corporation
Takara Holdings Inc
Novartis International AG
Bio-Techne Corporation

Chapter 1. Executive Summary
Chapter 2. Scope Of The Study: 2.1. Market Definition; 2.2. Scope Of The Study; 2.2.1. Objectives of Report; 2.2.2. Limitations; 2.3. Market Structure
Chapter 3. Evolve BI Methodology
Chapter 4. Market Insights and Trends: 4.1. Supply/ Value Chain Analysis; 4.1.1. Raw End Users Providers; 4.1.2. Manufacturing Process; 4.1.3. Distributors/Retailers; 4.1.4. End-Use Industry; 4.2. Porter’s Five Forces Analysis; 4.2.1. Threat Of New Entrants; 4.2.2. Bargaining Power Of Buyers; 4.2.3. Bargaining Power Of Suppliers; 4.2.4. Threat Of Substitutes; 4.2.5. Industry Rivalry; 4.3. Impact Of COVID-19 on the Gene Therapy Cell Culture Media Market; 4.3.1. Impact on Market Size; 4.3.2. End-Use Industry Trend, Preferences, and Budget Impact; 4.3.3. Regulatory Framework/Government Policies; 4.3.4. Key Players' Strategy to Tackle Negative Impact; 4.3.5. Opportunity Window; 4.4. Technology Overview; 12.28. Macro factor; 4.6. Micro Factor; 4.7. Demand Supply Gap Analysis of the Gene Therapy Cell Culture Media Market; 4.8. Import Analysis of the Gene Therapy Cell Culture Media Market; 4.9. Export Analysis of the Gene Therapy Cell Culture Media Market
Chapter 5. Market Dynamics: 5.1. Introduction; 5.2. DROC Analysis; 5.2.1. Drivers; 5.2.2. Restraints; 5.2.3. Opportunities; 5.2.4. Challenges; 5.3. Patent Analysis; 5.4. Industry Roadmap; 5.5. Parent/Peer Market Analysis
Chapter 6. Global Gene Therapy Cell Culture Media Market, By Product Type: 6.1. Introduction; 6.2. Media; 6.3. Viral Vectors
Chapter 7. Global Gene Therapy Cell Culture Media Market, By Application: 7.1. Introduction; 7.2. Biotechnology & Pharmaceutical Industry; 7.3. Research Laboratory; 7.4 Academic Institute; 7.5 Others
Chapter 8. Global Gene Therapy Cell Culture Media Market, By Region: 8.1. Introduction; 8.2. North America; 8.2.1. Introduction; 8.2.2. Driving Factors, Opportunity Analyzed, and Key Trends; 8.2.3. Market Size and Forecast, By Country, 2023-2033; 8.2.4. Market Size and Forecast, By Product Type, 2023-2033; 8.2.5. Market Size and Forecast, By End User, 2023-2033; 8.2.6. US; 8.2.6.1. Introduction; 8.2.6.2. Driving Factors, Opportunity Analyzed, and Key Trends; 8.2.6.3. Market Size and Forecast, By Product Type, 2023-2033; 8.2.6.4. Market Size and Forecast, By End User, 2023-2033; 8.2.7. Canada; 8.2.7.1. Introduction; 8.2.7.2. Driving Factors, Opportunity Analyzed, and Key Trends; 8.2.7.4. Market Size and Forecast, By Product Type, 2023-2033; 8.2.7.5. Market Size and Forecast, By End User, 2023-2033; 8.3. Europe; 8.3.1. Introduction; 8.3.2. Driving Factors, Opportunity Analyzed, and Key Trends; 8.3.3. Market Size and Forecast, By Country, 2023-2033; 8.3.4. Market Size and Forecast, By Product Type, 2023-2033; 8.3.5. Market Size and Forecast, By End User, 2023-2033; 8.3.6. Germany; 8.3.6.1. Introduction; 8.3.6.2. Driving Factors, Opportunity Analyzed, and Key Trends; 8.3.6.3. Market Size and Forecast, By Product Type, 2023-2033; 8.3.6.4. Market Size and Forecast, By End User, 2023-2033; 8.3.7. France; 8.3.7.1. Introduction; 8.3.7.2. Driving Factors, Opportunity Analyzed, and Key Trends; 8.3.7.3. Market Size and Forecast, By Product Type, 2023-2033; 8.3.7.4. Market Size and Forecast, By End User, 2023-2033; 8.3.8. UK; 8.3.8.1. Introduction; 8.3.8.2. Driving Factors, Opportunity Analyzed, and Key Trends; 8.3.8.3. Market Size and Forecast, By Product Type, 2023-2033; 8.3.8.4. Market Size and Forecast, By End User, 2023-2033; 8.3.9. Italy; 8.3.9.1. Introduction; 8.3.9.2. Driving Factors, Opportunity Analyzed, and Key Trends; 8.3.9.3. Market Size and Forecast, By Product Type, 2023-2033; 8.3.9.4. Market Size and Forecast, By End User, 2023-2033; 8.3.11. Rest Of Europe; 8.3.11.1. Introduction; 8.3.11.2. Driving Factors, Opportunity Analyzed, and Key Trends; 8.3.11.3. Market Size and Forecast, By Product Type, 2023-2033; 8.3.11.4. Market Size and Forecast, By End User, 2023-2033; 8.4. Asia-Pacific; 8.4.1. Introduction; 8.4.2. Driving Factors, Opportunity Analyzed, and Key Trends; 8.4.3. Market Size and Forecast, By Country, 2023-2033; 8.4.4. Market Size and Forecast, By Product Type, 2023-2033; 8.12.28. Market Size and Forecast, By End User, 2023-2033; 8.4.6. China; 8.4.6.1. Introduction; 8.4.6.2. Driving Factors, Opportunity Analyzed, and Key Trends; 8.4.6.3. Market Size and Forecast, By Product Type, 2023-2033; 8.4.6.4. Market Size and Forecast, By End User, 2023-2033; 8.4.7. India; 8.4.7.1. Introduction; 8.4.7.2. Driving Factors, Opportunity Analyzed, and Key Trends; 8.4.7.3. Market Size and Forecast, By Product Type, 2023-2033; 8.4.7.4. Market Size and Forecast, By End User, 2023-2033; 8.4.8. Japan; 8.4.8.1. Introduction; 8.4.8.2. Driving Factors, Opportunity Analyzed, and Key Trends; 8.4.8.3. Market Size and Forecast, By Product Type, 2023-2033; 8.4.8.4. Market Size and Forecast, By End User, 2023-2033; 8.4.9. South Korea; 8.4.9.1. Introduction; 8.4.9.2. Driving Factors, Opportunity Analyzed, and Key Trends; 8.4.9.3. Market Size and Forecast, By Product Type, 2023-2033; 8.4.9.4. Market Size and Forecast, By End User, 2023-2033; 8.4.10. Rest Of Asia-Pacific; 8.4.10.1. Introduction; 8.4.10.2. Driving Factors, Opportunity Analyzed, and Key Trends; 8.4.10.3. Market Size and Forecast, By Product Type, 2023-2033; 8.4.10.4. Market Size and Forecast, By End User, 2023-2033; 8.5. Rest Of The World (RoW); 8.5.1. Introduction; 8.5.2. Driving Factors, Opportunity Analyzed, and Key Trends; 8.5.3. Market Size and Forecast, By Product Type, 2023-2033; 8.5.4. Market Size and Forecast, By End User, 2023-2033
Chapter 9. Company Landscape: 9.1. Introduction; 9.2. Vendor Share Analysis; 9.3. Key Development Analysis; 9.4. Competitor Dashboard
Chapter 10. Company Profiles: 10.1. Fujifilm Holdings Corporation; 10.1.1. Business Overview; 10.1.2. Government & Defense Analysis; 10.1.2.1. Government & Defense – Existing/Funding; 10.1.3. Product Portfolio; 10.1.4. Recent Development and Strategies Adopted; 10.1.5. SWOT Analysis; 10.2. HiMedia Laboratories; 10.2.1. Business Overview; 10.2.2. Government & Defense Analysis; 10.2.2.1. Government & Defense – Existing/Funding; 10.2.3. Product Portfolio; 10.2.4. Recent Development and Strategies Adopted; 10.2.5. SWOT Analysis; 10.3. Lonza Group Ltd.; 10.3.1. Business Overview; 10.3.2. Government & Defense Analysis; 10.3.2.1. Government & Defense – Existing/Funding; 10.3.3. Product Portfolio; 10.3.4. Recent Development and Strategies Adopted; 10.3.5. SWOT Analysis; 10.4. Sartorius AG; 10.4.1. Business Overview; 10.4.2. Government & Defense Analysis; 10.4.2.1. Government & Defense – Existing/Funding; 10.4.3. Product Portfolio; 10.4.4. Recent Development and Strategies Adopted; 10.12.28. SWOT Analysis; 10.5. Thermo Fisher Scientific Inc.; 10.5.1. Business Overview; 10.5.2. Government & Defense Analysis; 10.5.2.1. Government & Defense – Existing/Funding; 10.5.3. Product Portfolio; 10.5.4. Recent Development and Strategies Adopted; 10.5.5. SWOT Analysis; 10.6. Merck KGaA; 10.6.1. Business Overview; 10.6.2. Government & Defense Analysis; 10.6.2.1. Government & Defense – Existing/Funding; 10.6.3. Product Portfolio; 10.6.4. Recent Development and Strategies Adopted; 10.6.5. SWOT Analysis; 10.7. Danaher Corporation; 10.7.1. Business Overview; 10.7.2. Government & Defense Analysis; 10.7.2.1. Government & Defense – Existing/Funding; 10.7.3. Product Portfolio; 10.7.4. Recent Development and Strategies Adopted; 10.7.5. SWOT Analysis; 10.8 Takara Holdings Inc; 10.8.1. Business Overview; 10.8.2. Government & Defense Analysis; 10.8.2.1. Government & Defense – Existing/Funding; 10.8.3. Product Portfolio; 10.8.4. Recent Development and Strategies Adopted; 10.8.5. SWOT Analysis; 10.9 Novartis International AG; 10.9.1. Business Overview; 10.9.2. Government & Defense Analysis; 10.9.2.1. Government & Defense – Existing/Funding; 10.9.3. Product Portfolio; 10.9.4. Recent Development and Strategies Adopted; 10.9.5. SWOT Analysis; 10.10. Bio-Techne Corporation.; 10.10.1. Business Overview; 10.10.2. Government & Defense Analysis; 10.10.2.1. Government & Defense – Existing/Funding; 10.10.3. Product Portfolio; 10.10.4. Recent Development and Strategies Adopted; 10.10.5. SWOT Analysis